Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar 1;23(131):118-30.
doi: 10.1183/09059180.00004413.

Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype

Affiliations
Review

Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype

Mallory Pain et al. Eur Respir Rev. .

Abstract

Airway remodelling is a critical feature of chronic bronchial diseases, characterised by aberrant repair of the epithelium and accumulation of fibroblasts, which contribute to extracellular matrix (ECM) deposition resulting in fixed bronchial obstruction. Recently, epithelial-mesenchymal transition (EMT) has been identified as a new source of fibroblasts that could contribute to the remodelling of the airways. This phenomenon consists of the loss of the epithelial phenotype by bronchial epithelial cells and the acquisition of a mesenchymal phenotype. These cells are then able to migrate and secrete ECM molecules. Herein, we review the different types of EMT. We will then focus on the signalling pathways that are involved, such as transforming growth factor-β and Wnt, as well as the more recently described Sonic Hedgehog pathway. Finally, we will highlight the implication of EMT in airway remodelling in specific chronic bronchial pathologies, such as asthma, chronic obstructive pulmonary disease and bronchiolitis obliterans following lung transplantation. Despite the limitations of in vitro models, future studies of EMT in vivo are warranted to shed new light on the pathomechanisms of bronchial obstruction.

PubMed Disclaimer

Conflict of interest statement

Statement of Interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

Figures

Figure 1.
Figure 1.
Epithelial–mesenchymal transition type III; an example of alveolar carcinoma.
Figure 2.
Figure 2.
Epithelial–mesenchymal transition (EMT) type II in bronchial remodelling. ECM: extracellular matrix.
Figure 3.
Figure 3.
Cell signalling involved in epithelial–mesenchymal transition. ZO: zonula occudens; Wnt: wingless tail; Hh: Hedgehog; SMO: Smoothened; GSK-3β: glycogen synthase kinase-3β; Ptch: Patched; MAPK: mitogen activated protein kinase; PI3K: phosphatidylinositol 3-kinase; Zeb: zinc finger E box binding homeobox; MMP: matrix metalloproteinase; TGF: transforming growth factor; BMP7: bone morphogenetic protein 7; P: phosphate.

References

    1. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233: 706–720. - PubMed
    1. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442–454. - PubMed
    1. Ikenouchi J, Matsuda M, Furuse M, et al. . Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116: 1959–1967. - PubMed
    1. Ozdamar B, Bose R, Barrios-Rodiles M, et al. . Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science 2005; 307: 1603–1609. - PubMed
    1. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 1995; 10: 171–184. - PubMed

Publication types

LinkOut - more resources